Global Monopoly of Technology

At this time, Lu Zhengyang introduced their technical achievements in an orderly manner: "After more than a year of research and development, this nano-robot has finally been launched. I think it is necessary to say that this kind of nano-robot can be used in addition to In addition to acting as a killer weapon that physically kills cancer cells, it can also be used as a transport vehicle to carry therapeutic drugs."

"If it is used as the former, this nanorobot is not mature enough at present, and there is still room for further improvement before clinical trials, but we have also purchased a set of organ simulators from Huachang Technology for testing."

Lu Zhengyang is also very candid, saying one thing instead of fooling people and talking big.

"As far as our experiments are concerned, it cannot destroy the specified cancer cells in the cell group, and any cells around this type of nanorobot, whether good or bad, will be indiscriminately subjected to 'suicide'. Spiral attack'."

The people present were quite astonished when they heard it. This nano-robot is now in a rhythm that is indistinguishable between enemy and foe. Whether it is a normal cell or a cancer cell, it will be destroyed for you.

But this characteristic makes some people have other ideas. There are all kinds of people at the expo site, and there is naturally no shortage of intelligence agencies from various countries.

In the exhibition area where Lu Zhengyang was located, foreign intelligence personnel were watching as tourists. After hearing such an explanation, the first thought that came to his mind was biological and chemical weapons.

The properties of this nanorobot are enough to kill people on a microscopic scale.

The two co-founders, Lu Zhengyang and Zhao Yu, never thought of weaponizing the technology they researched. They have always been committed to benefiting mankind. It can be explained that the co-founded company belongs to the medical device industry.

Different positions have yielded different results, once again explaining that technology is a double-edged sword.

Lu Zhengyang said: "The organ simulator we purchased from Huachang Technology will arrive soon. Next, our team will carry out the next stage of microbiological experimental tests on it, and continue to improve this nanorobot. I believe that in the future its The application must be able to truly bring the gospel to mankind.”

After the voice fell, he received a warm applause.

Ding Xian didn't stay in front of the stage for too long, and whispered a few times with the accompanying secretary assistant. After about ten minutes, he left the stage and met with Lu Zhengyang behind the scenes at the Hongrui Medical booth.

At the backstage, Ding Xiancai unexpectedly found that besides him, there were many other VCs who came before him, smiling and nodding to each other.

But Ding Xian knew,

On the surface, they nodded and smiled at each other and questioned each other, but most of them were scolding each other in their hearts.

In the next half an hour, Lu Zhengyang met and discussed with several VCs who came to visit. Hongrui Medical has only been established for about three years, but it has already completed the B round of financing, and without exception, it is funded by Cote d'Azur, Shengfeng Capital invested, and did not accept other venture capital institutions.

Because the agreement between Hongrui Medical and Azure Coast and Shengfeng Capital is that if the company wants to carry out external financing, Azure Coast and Shengfeng Capital have priority and exclusive investment. Unless the priority and exclusive investment are waived, other VC institutions will not be able to access Hongrui. Ray's car.

Therefore, the previous financing was funded by Luo Sheng's institution, and other VC institutions were very helpless, but they did not do the same.

However, these VC institutions have been watching, and by the time of the next C round of financing, they have already received news that Luo Sheng will let other VCs get on board. This is not an exception. Many Cote d'Azur strategic investment departments, Sheng The potential investment projects that Feng Capital was interested in, the C rounds used to be eaten alone, and they have been shared since the C rounds.

Doing this ensures that you can eat the biggest piece of the cake, and at the same time let some people come in to make a fortune together. Of course, there is a possibility that the investment may fail, so let’s take risks together.

However, most investment institutions are very enthusiastic, because Luo Sheng has almost no precedent for overturning, as long as he lets go, VC will not hesitate to throw money in, because Luo Sheng is on this table, everyone is very at ease, even if I can't understand the model and future of a company, but as long as Luo Sheng is in the car, VCs don't think much about it at all, they close their eyes and they're done, and they can basically get a bite of meat with President Luo.

About an hour later, Ding Xian left here, and he was quite satisfied when he came out from the backstage, because he also successfully got into the car.

The C-round financing of Hongrui Medical was successfully negotiated within this hour. There were 6 venture capital institutions participating in this round of financing, led by Shengfeng Capital. The C-round financing totaled 75 million US dollars, or about 500 million yuan.

After the C round of financing, Hongrui Medical’s valuation was US$1.15 billion. This valuation given by the capital market means that another unicorn-level start-up technology company has been born in the technology industry.

Once the nano-robot developed by Hongrui Medical has made a major breakthrough, the future prospects are boundless imagination.

Although it seems that the day of success is still far away, the technical progress made by Lu Zhengyang's team is visible, which gives investors great confidence, willing to take greater risks and give Hongrui Medical a higher Valuation and expect it to thrive.

...

Cote d'Azur CEO Office.

Luo Sheng stood near the window of his office and silently overlooked the expo site below. The location of his office has a very good view. Standing next to the floor-to-ceiling windows, the expo site is unobstructed.

Today is the second day of the exhibition, and it is crowded with people and bustling, so lively.

At this time, the door of the office was knocked several times.

"Come in."

Luo Sheng turned around and looked, and it was Yao Jianhong who walked in.

"The leader of the CSRC has left?" Luo Sheng came over from the floor-to-ceiling window and sat down on the sofa in the lounge area of ​​the office.

Yao Jianhong, who was sitting opposite him, nodded: "Well, let's go, basically we've negotiated."

The leaders of the China Securities Regulatory Commission came to the Côte d'Azur in person this time for a very important event for Big A next year - the opening of the Science and Technology Innovation Board.

The Science and Technology Innovation Board is a new board that is independent from the existing main board market of Big A, and a registration-based pilot program will be carried out in this board.

Undoubtedly, this is a very important new sector, which the country attaches great importance to, and its market positioning is the strategy of innovation-driven and technological power.

If the Science and Technology Innovation Board is to open, it will definitely require a group of high-quality innovative companies to land on the Science and Technology Innovation Board, and the new startups that can be called brand names that have not been listed are basically the Cote d'Azur.

Really catch a lot.

The Sci-Tech Innovation Board would not be representative without the listing of technology companies from the Côte d'Azur.

In fact, the China Securities Regulatory Commission has repeatedly studied the possibility of whether the Cote d'Azur company can be listed on the Science and Technology Innovation Board, and directly chose to give up after the study.

First, it is necessary to lobby Luo Sheng for the listing of Cote d'Azur, and the CSRC also knows that Luo Sheng will not let the company go public, including Hua Wei, because there is no shortage of money at all, and there is no need for margin financing and securities lending.

And another reason that cannot be ignored is just as important. With the current size of the Côte d’Azur, it would be incredible to open the market on the Science and Technology Innovation Board.

The entire sector has to be broken by this big guy. If the Cote d'Azur goes public, don't think about it, its valuation must start at 20 trillion yuan, and it will start at 3 trillion US dollars excluding exchange rate changes.

The blood of the entire Big A stock market has to be drained by this company, and it may not be able to recover in two or three years, so the China Securities Regulatory Commission gave up.

The big A motherboard already has the super giant, the Blue Pure Electric Vehicle Company, with a current market value of 11.47 trillion.

The conclusion is that the current big A is not enough to carry two super giants at the same time.

However, the opening of the Sci-Tech Innovation Board has already set the tone, but the outside world does not yet know about this matter. The specific opening time has not been announced. Only a few institutions have been notified, and the Côte d’Azur is one of them.

Obviously, the STAR Market cannot be opened without high-quality stocks, and it must be opened beautifully.

"The first batch of listed companies on the Science and Technology Innovation Board is set to be 28. The CSRC hopes that we can provide 10 high-quality stocks as heavyweight stocks to open the market on the Science and Technology Innovation Board. There are a total of 35 companies selected from the company, Mr. Luo, please take a look."

Yao Jianhong put the documents he brought on the table and pushed them to Luo Sheng, who opened the list on the list.

Lao Yao has selected 35 companies, but the final decision on the 10 companies listed on the Science and Technology Innovation Board is left to Luo Sheng to make the decision.

The first to bear the brunt is Xiongxin Electronics, the largest chip foundry in China, and it is also the one with the highest valuation among the first batch of 28 listed companies on the Science and Technology Innovation Board. A total of 215 billion US dollars, this valuation is only less than 20 billion US dollars away from the current market value of the performance leader LSMC.

Once Xiongxin Electronics is listed on the Science and Technology Innovation Board, it will undoubtedly become an absolute leading stock, far ahead of other listed companies on the Science and Technology Innovation Board.

Even if it is placed in the entire Big A, its market value ranking is also ranked fifth, and the newly opened Science and Technology Innovation Board really needs such a needle of Ding Hai Shen, which is a proper brand.

"Xiongxin Electronics... um."

Luo Sheng watched for a while, then immediately took a pen and tickled the company's directory, which meant that he agreed with Xiongxin Electronics to be listed on the Science and Technology Innovation Board. .

The second is Jingchuang Technology, the most potential start-up company for EDA software development in China, with a valuation of 57 billion yuan.

The third is engaged in the field of medical devices. Huachang Technology, founded by Cao Junhui, focuses on the development of organ simulators. It has achieved profitability and has business dealings with major biomedical R\u0026D giants in the world. The valuation given is 320 billion yuan.

The fourth company is Bochuang Technology, which develops human bionic prostheses. The company founded by Chen Xin after the 1990s also achieved profitability, with a valuation of 178 billion yuan.

"Just these 10, report them to the China Securities Regulatory Commission."

About ten minutes later, Luo Sheng selected 10 companies from the 35 companies selected by Lao Yao to log on the Science and Technology Innovation Board and returned the documents to him.

"Okay, I'll deal with it now." Yao Jianhong took the documents and left Luo Sheng's office.

There is no doubt that these 10 companies that will soon be listed on the Science and Technology Innovation Board are the best targets for value investment, and they are definitely the most popular stocks for price investment.

The industries in which these 10 companies are located are the chip semiconductor and medical device industries. What we can meet is that the trend of the technology and medical industry in 2019 next year will surely usher in a sector bull market.

...